CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
BVR-100 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06037668
NCT06037668N/ACompleted

BVR-100 and BES-100 Validation Trial: A Randomized, Double-Blind, Parallel-Group, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

Sumitomo Pharma America, Inc.·interventional·Posted Sep 14, 2023·Updated Mar 12, 2025

In Brief

A clinical study evaluating BVR-100 and BES-100 for Social Anxiety Disorder (SAD). Completed, enrolled 56 participants across 6 sites.

Detailed Summary

This study is to compare two Virtual Reality (VR)-based interventions, BVR-100 and BES-100, for the treatment of Social Anxiety Disorder (SAD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsBehaVR LLC

Timeline

N/ACompletedFinished
202420252026
First PostedSep 14, 2023
Enrollment StartSep 8, 2023
Primary CompletionDec 22, 2023
Study CompletionJan 10, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.8 years ago

Interventions

BVR-100device

Experimental self-guided VR intervention for the treatment of SAD

BES-100device

Active at-home VR intervention comparator